NDC 63323-194-05
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-194
- Requested NDC
- 63323-194-05
- Package NDCs from labels
- 63323-194-05
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-194-05 | ML - Milliliter | 63323-194 | c3bc4d48-618b-4381-b5be-ce6e47d5f72c | 1 | 2012-07-24 |
| 63323-194-10 | ML - Milliliter | 63323-194 | 2ddf230f-6a0d-49ba-aae9-02378ddc8261 | 1 | 2012-07-24 |
| 63323-194-20 | ML - Milliliter | 63323-194 | 47c3b2a6-a499-4223-acc8-7c926c4d8140 | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TYENNE | TOCILIZUMAB-AAZG | Fresenius Kabi USA, LLC | ad76441d-da59-47df-8d9d-2243005180f0 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e88 | 2026-08-20 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| sugammadex | SUGAMMADEX | Fresenius Kabi USA, LLC | 8e685b67-6804-4d97-b43e-0259b3fe231f | 2026-08-03 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Rocuronium | ROCURONIUM BROMIDE | Fresenius Kabi USA, LLC | 04c9812d-5aa3-4949-ad02-c618028f1bb0 | 2026-08-02 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Morphine Sulfate | MORPHINE SULFATE | Fresenius Kabi USA, LLC | 582f42e5-444e-4246-af8c-e7e28097c69a | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| EPINEPHRINE | EPINEPHRINE | Fresenius Kabi USA, LLC | a6afb9e8-1db9-480c-8d31-58c5c870ca49 | 2026-07-29 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| TYENNE | TOCILIZUMAB-AAZG | Fresenius Kabi USA, LLC | 87ac5047-4f2b-4571-a8a8-32e08865f379 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | cb6583ff-cde4-4280-aa5b-0bea2b844792 | 2026-07-17 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Dilaudid | HYDROMORPHONE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 9eebd88a-5632-460f-b7b6-26c8a180540d | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Fresenius Kabi USA, LLC | e034eb96-03e0-46e1-8b92-5e1f94555e7b | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Fluorouracil | FLUOROURACIL | Fresenius Kabi USA, LLC | beb8c6c5-4b6e-4770-b6d4-718e33c7a2ff | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| EPINEPHRINE | EPINEPHRINE | Fresenius Kabi USA, LLC | 4f83895f-638c-4515-af03-7c41ae60a42e | 2026-07-15 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Calcitonin Salmon | CALCITONIN SALMON | Fresenius Kabi USA, LLC | 2b8c6917-c217-45bf-a0ac-a2fa0f7d497a | 2026-07-15 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Etoposide | ETOPOSIDE | Fresenius Kabi USA, LLC | fe870629-104d-4d67-a7c6-f53bc588121e | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | cca2c160-9188-48e8-9505-49a52388dcb7 | 2026-06-30 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | 7cbd9005-7df2-47ee-adb3-7244c1c69bc3 | 2026-06-30 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Deferoxamine | DEFEROXAMINE MESYLATE | Fresenius Kabi USA, LLC | d91e16df-8daa-4cd2-86a2-273eaa2446e0 | 2026-06-15 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Fluorouracil | FLUOROURACIL | Fresenius Kabi USA, LLC | b4328ae3-f48f-40b1-9719-1c1aced7c734 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Fluorouracil | FLUOROURACIL | Fresenius Kabi USA, LLC | a85ab26a-05ea-498f-8f34-564a925fa9d9 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.